Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells
============================================================================================================================

* Maxwell Y Lee
* Yvette Robbins
* Cem Sievers
* Jay Friedman
* Houssein Abdul Sater
* Paul E Clavijo
* Nancy Judd
* Edward Tsong
* Chris Silvin
* Patrick Soon-Shiong
* Michelle R Padget
* Jeffrey Schlom
* James Hodge
* Christian Hinrichs
* Clint Allen